Axol Bioscience
Axol Bioscience supports your pursuit of more effective, safer therapies. They use induced pluripotent stem cells (iPSCs) to build more relevant models of human disease to expand your understanding and de-risk drug development.
Latest Content
Video
The Use of Human iPSC-derived Cells in Disease Modeling
Speaking at the Innovations in Disease Modeling online symposium, Steven Broadbent delivered his talk on the use of human iPSC-derived cells in disease modeling.
Product News
Axol Bioscience Introduces CiPA-Validated Human Stem Cell-Derived Ventricular Cardiomyocytes To Help Improve Drug Discovery
Axol Bioscience Ltd. has announced that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitro pro-arrhythmia assay (CiPA) validation.
Advertisement
